[1]Nikolich-Zugich J, Knox KS, Rios CT, et al. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes[J]. Geroscience, 2020, 42: 505-514. [2]Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020, 382: 727-733. [3]Goes LR, Siqueira JD, Garrido MM, et al. New infections by SARS-CoV-2 variants of concern after natural infections and post-vaccination in Rio de Janeiro, Brazil[J]. Infect Genet Evol, 2021, 94: 104998. doi: 10.1016/j.meegid.2021.104998. [4]Zambrano LD, Ellington S, Strid P, et al. Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States, January 22-October 3, 2020[J]. MMWR Morb Mortal Wkly Rep, 2020, 69: 1641-1647. [5]Rasmussen SA, Kelley CF, Horton JP, et al. Coronavirus disease 2019 (COVID-19) vaccines and pregnancy: what obstetricians need to know[J]. Obstet Gynecol, 2021, 137: 408-414. [6]Tekbali A, Grunebaum A, Saraya A, et al. Pregnant vs nonpregnant severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 hospital admissions: the first 4 weeks in New York[J]. Am J Obstet Gynecol, 2020, 223: 126-127. [7]Westgren M, Acharya G. Intensive care unit admissions for pregnant and nonpregnant women with coronavirus disease 2019[J]. Am J Obstet Gynecol, 2020, 223: 779-780. [8]张露,江燕,魏敏,等.湖北地区新型冠状病毒肺炎流行期间孕妇的妊娠结局分析[J].中华妇产科杂志,2020,55: 166-171. [9]Ellington S, Strid P, Tong VT, et al. (2020) Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States, January 22-June 7, 2020[J]. MMWR Morb Mortal Wkly Rep, 2020, 69: 769-775. [10]Khalil A, Kalafat E, Benlioglu C, et al. SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis of clinical features and pregnancy outcomes[J]. EClinicalMedicine, 2020, 25: 100446. doi: 10.1016/j.eclinm.2020.100446. [11]Magee LA, Khalil A, von Dadelszen P. Covid-19: UK Obstetric Surveillance System (UKOSS) study in context[J]. BMJ, 2020, 370: m2915. doi: 10.1136/bmj.m2915. [12]Patel MK, Bergeri I, Bresee JS, et al. (2021) Evaluation of post-introduction COVID-19 vaccine effectiveness: summary of interim guidance of the World Health Organization[J]. Vaccine, 2021, 39: 4013-4024. |